Valuation: Nephros, Inc.

Market Cap 34.43M 30.84M 28.45M 25.74M 48.14M 3.28B 48.92M 339M 135M 1.72B 129M 126M 5.43B P/E 2026 *
20.9x
P/E 2027 * 12.6x
Enterprise Value 34.43M 30.84M 28.45M 25.74M 48.14M 3.28B 48.92M 339M 135M 1.72B 129M 126M 5.43B EV / Sales 2026 *
1.56x
EV / Sales 2027 * 1.34x
Free-Float
80.55%
Yield 2026 *
-
Yield 2027 * -
1 day+3.15%
1 week-8.91%
Current month-11.86%
1 month-18.86%
3 months-6.57%
6 months-1.51%
Current year-32.99%
1 week 3.08
Extreme 3.085
3.77
1 month 3.01
Extreme 3.01
3.89
Current year 2.66
Extreme 2.6629
5.46
1 year 2.66
Extreme 2.6629
6.42
3 years 1.36
Extreme 1.3643
6.42
5 years 0.91
Extreme 0.9051
8.15
10 years 0
Extreme 0
11.67
Manager TitleAgeSince
Chief Executive Officer 51 05/05/2023
Director of Finance/CFO 61 01/11/2023
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 69 19/09/2007
Director/Board Member 55 10/08/2018
Director/Board Member 58 08/09/2022
Date Insider Type Main position Quantity % Market Cap. Importance
9/14/26 A
Wexford Capital LP
OthersCompany -3,377,821 31.1030%
9/14/26 A Others

Director

43,295 0.3987%
8/12/26 A Free

Director

2,418 0.0223%
Change 5-day change 1-year change 3-year change Capi.($)
+3.15%-8.91%-43.03%+103.11% 34.43M
+2.55%+0.57%+13.06%+43.08% 90B
+1.23%+2.59%+8.52%+61.84% 71.47B
+1.23%+8.14%+4.50%+42.12% 44.97B
+1.23%+2.71%+1.49%+53.05% 25.06B
+3.33%+2.96%+0.22%+61.01% 18.92B
-1.26%-3.11%+25.65%+104.83% 16.54B
+0.27%-3.79%+3.03%+48.85% 9.86B
+3.56%+8.67%+16.91%+31.55% 9.42B
+2.01%+0.10%+2.73%+22.84% 5.63B
Average +1.76%-0.72%+3.31%+57.23% 29.19B
Weighted average by Cap. +1.79%+0.77%+9.10%+52.48%

Financials

2026 *2027 *
Net sales 22.14M 19.83M 18.29M 16.55M 30.95M 2.11B 31.45M 218M 87.06M 1.1B 83.07M 81.3M 3.49B 25.66M 22.98M 21.2M 19.18M 35.87M 2.44B 36.45M 253M 101M 1.28B 96.28M 94.23M 4.05B
Net income 1.76M 1.58M 1.46M 1.32M 2.47M 168M 2.51M 17.39M 6.94M 87.93M 6.62M 6.48M 278M 2.92M 2.61M 2.41M 2.18M 4.08M 278M 4.14M 28.75M 11.47M 145M 10.94M 10.71M 460M
Net Debt - -
Projected Income Statement - Annual - Nephros, Inc.
Logo Nephros, Inc.
Nephros, Inc. is a water technology company providing filtration solutions to the medical and commercial markets. The Company provides water filtration products and services, along with water-quality education. In the medical markets, it sells water filtration products. In the commercial market, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, heavy metals, chemical compounds, scale build-up in downstream equipment, and various other contaminants. Its products are marketed primarily to the food service, hospitality, convenience store, and healthcare markets. These commercial products are also marketed in medical markets as supplemental filtration to its medical filters. Its filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.
Employees
36
Date Price Change Volume
29/10/26 $3.270 +3.15% 72,436
28/10/26 $3.170 -9.69% 236,015
27/10/26 $3.510 -3.31% 46,867
26/10/26 $3.630 +2.83% 39,086
23/10/26 $3.530 +0.28% 45,495
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Nephros, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
3.170USD
Average target price
6.250USD
Spread / Average Target
+97.16%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Nephros, Inc.
  1. Stock Market
  2. Stocks
  3. NEPH Stock